MedTrace Logo

Optimizing Surgical Conditions During Gynecologic Laparoscopic Surgery With Deep Neuromuscular Blockade

NCT01933425 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2015-03-30

Study results available
· View outcomes & findings →

Summary

To investigate if deep neuromuscular blockade improves intraabdominal volume compared to no neuromuscular blockade in patients scheduled for gynecologic laparoscopic surgery with pneumoperitoneum 12 mmHg.

Hypothesis:

Deep neuromuscular blockade improves intraabdominal space (the distance from promontorium to skin surface, cm) compared to no neuromuscular blockade.

Conditions

  • Neuromuscular Blockade

Interventions

DRUG

rocuronium

DRUG

sugammadex

DRUG

placebo

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Principal Investigators

  • Matias Vested Madsen, MD · Department of Anesthesiology Herlev Hospital

  • Olav Istre, MD, DMSc, professor · Department of minimal invasive gynecology, Aleris-Hamlet, Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01933425 on ClinicalTrials.gov